Evidence map›Paper›PMID 26227667›Full record

ArticleImmunology2015

Guanine polynucleotides are self-antigens for human natural autoantibodies and are significantly reduced in the human genome.

Ittai Fattal, Noam Shental, Shifra Ben-Dor, Yair Molad, Armando Gabrielli, Elisheva Pokroy-Shapira, Shirly Oren, Avi Livneh, Pnina Langevitz, Gisele Zandman-Goddard and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Ittai FattalDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Noam ShentalDepartment of Computer Science, The Open University of Israel, Raanana, Israel.
Shifra Ben-DorBioinformatics and Biological Computing Unit, The Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-9604-1939
Yair MoladThe Rheumatology Unit, Rabin Medical Centre, Beilinson Hospital, Petach Tikva, Israel.
Armando GabrielliIstituto di, Dipartimento di Scienze Cliniche e Molecolari- Clinica Medica, Università Politecnica delle Marche, Ancona, Italy.
Elisheva Pokroy-ShapiraThe Rheumatology Unit, Rabin Medical Centre, Beilinson Hospital, Petach Tikva, Israel.
Shirly OrenThe Rheumatology Unit, Rabin Medical Centre, Beilinson Hospital, Petach Tikva, Israel.
Avi LivnehDepartment of Medicine F, Sheba Medical Centre, Tel Hashomer, Israel.
Pnina LangevitzThe Rheumatology Unit, Sheba Medical Centre, Tel Hashomer, Israel.
Gisele Zandman-GoddardDepartment of Medicine C, Wolfson Medical Centre, Holon, Israel.
Ofer SarigDepartment of Dermatology, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel.
Raanan MargalitScience in Action Ltd, Weizmann Science Park, Ness-Ziona, Israel.
Uzi GafterDepartment of Nephrology, Rabin Medical Centre, Petach Tikva, Israel.
Eytan DomanyDepartment of Physics of Complex Systems, The Weizmann Institute of Science, Rehovot, Israel.
Irun R CohenDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
Weizmann Institute of Science · ILTel Aviv University · ILRabin Medical Center · ILSheba Medical Center · ILMarche Polytechnic University · ITOpen University of Israel · ILTel Aviv Sourasky Medical Center · ILWolfson Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the course of investigating anti-DNA autoantibodies, we examined IgM and IgG antibodies to poly-G and other oligonucleotides in the sera of healthy persons and those diagnosed with systemic lupus erythematosus (SLE), scleroderma (SSc), or pemphigus vulgaris (PV); we used an antigen microarray and informatic analysis. We now report that all of the 135 humans studied, irrespective of health or autoimmune disease, manifested relatively high amounts of IgG antibodies binding to the 20-mer G oligonucleotide (G20); no participants entirely lacked this reactivity. IgG antibodies to homo-nucleotides A20, C20 or T20 were present only in the sera of SLE patients who were positive for antibodies to dsDNA. The prevalence of anti-G20 antibodies led us to survey human, mouse and Drosophila melanogaster (fruit fly) genomes for runs of T20 and G20 or more: runs of T20 appear > 170,000 times compared with only 93 runs of G20 or more in the human genome; of these runs, 40 were close to brain-associated genes. Mouse and fruit fly genomes showed significantly lower T20/G20 ratios than did human genomes. Moreover, sera from both healthy and SLE mice contained relatively little or no anti-G20 antibodies; so natural anti-G20 antibodies appear to be characteristic of humans. These unexpected observations invite investigation of the immune functions of anti-G20 antibodies in human health and disease and of runs of G20 in the human genome.

Indexed as

AnimalsAntibodies, AntinuclearAutoantibodiesAutoantigensCase-Control StudiesCpG IslandsDrosophila melanogasterFemaleGenome, HumanGenome, InsectHumansImmunity, InnateImmunoglobulin GImmunoglobulin MLupus Erythematosus, SystemicMiceAntibodies, AntinuclearAutoantibodiesAutoantigensImmunoglobulin GImmunoglobulin MPoly GPoly Tantigens/peptides/epitopesautoantibodieshuman

Identifiers

PMID26227667
PMCPMC4610629
OpenAlexW1871941524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.